The invention relates to a biocompatible, neural implant for recording neural signals in a living being. In particular, the present invention discloses an acquisition system for neural signals within a chip for implantation in a living being.
A biopotential is an electrical potential that is measured between points in living cells, tissue and organisms and occurs in connection with all biochemical processes. It also describes the transfer of information between and within cells. It is an electrical quantity (voltage, current or field strength) that is caused by chemical reactions of charged ions. The term is further used in the description of the transfer of information between and within cells, for example in signal transmission.
Neural implants can electrically stimulate, capture and block (or even simultaneously capture and stimulate) signals from individual neurons or groups of neurons (biological neural networks) in a living being.
The present invention discloses the design and test of an integrated CMOS biopotential acquisition chip having 8 channels and consisting of a low-noise amplifier (LNA), a second stage, a multiplexer and two analogue-to-digital converters (ADC).
Due to its variable power consumption, the integrated noise of the first stage can be reduced from 1.94 to 0.693 μVRMS (ISS=250 μA). The device has variable lower and upper corner frequencies and outputs two 16-bit digital data streams at 1 Mb/s.
The chip die is manufactured in X-Fab 0.35 μm CMOS technology and has an area of 10 mm2.
Neural implants are devices that support the treatment of diseases such as Parkinson's disease, hearing impairments and heart defects.
Such devices connect the neural system by electrical stimulation to induce a reaction of the body. For example, cochlear implants stimulate the auditory nerve to create the sensory impression of hearing, pacemakers stimulate the inner wall of the heart to trigger heart muscle contractions, and deep brain stimulators generate signals that prevent unwanted muscle twitches caused by Parkinson's disease.
Medical research aims to understand how neural implants should affect the neural system. Normally, large recording systems are used in experiments on humans and animals that make it possible to visualize and process signals from the brain or nerves. Current experiments show a clear tendency towards the use of implantable acquisition systems, as they are one step closer to the reality of medical implants.
Depending on the type of application, bioelectric signals cover a wide range of amplitudes, noise levels and frequency bands. For this reason, a recording system that can adapt its properties to the respective applications is extremely desirable.
Ghovanloo shows a system with an extremely low power consumption that can detect brain signals and includes a variable bandwidth and radio transmission. M. Yin and M. Ghovanloo, “A low-noise clockless simultaneous 32-channel wireless neural recording system with adjustable resolution,” Analog Integrated Circuits and Signal Processing, vol. 66, no. 3, S. 417-431, ISI:000287319400010, 2011. Harrison et al. shows a versatile acquisition amplifier which has proven itself in the case of brain action potentials, electroencephalography (EEG), electrocardiography (ECG) and electromyography (EMG).
A disadvantage of these acquisition systems is their noise level of 4 μVRMs and 2 l μVRMS each, which is relatively high in applications with EEG and electroneurography (ENG).
Amplifiers also generate noise, which is divided into thermal noise and flicker noise.
The thermal noise density is constant with respect to the frequency and is proportional to the equivalent resistance of the transistor.
The flicker noise density, on the other hand, depends on the frequency with a factor of 1/f and is inversely proportional to the transistor surface.
Some effort has already been put into overcoming noise limitation. A notable work is represented by the BJT input transconductance operational amplifier (OTA) for ENG, proposed by R. Rieger and N. Donaldson.
Since BJT transistors do not generate flicker noise, the resulting input-related noise of 300 nVRMS is significantly lower than that of previous amplifiers. However, this architecture has two serious disadvantages:
In addition, a chopper structure was proposed that shifts the signal to a frequency at which the flicker noise is negligible. The signal is then demodulated without flicker noise. Unfortunately, the chopper amplifier needs at least ten times more bandwidth to ensure that the signal is sufficiently far away. This requirement increases the power consumption of the amplifier.
The present invention shows a versatile, low-noise amplifier to achieve an input noise level of sub-μVRMS. The applied approach to noise reduction consists in an appropriate transistor size and power and in using PMOS input transistors with a lower flicker noise constant. The present system shown in
It is known that the first stage (preamplifier) is the most important stage in an amplifier chain, as it is the component which is most susceptible to noise. For this reason, a fully-differential telescopic architecture has been used.
The architecture shown in
The equations of the amplifier channels are known, and rephrased for the gm/ID design methodology, the noise model is as follows:
And the transfer function:
Legend:
Using the PMOS transistors and the optimal point marked in
The second stage shown in
In the field of electronics, the Miller effect is the increase in the equivalent input capacitance of an inverting voltage amplifier due to the amplification of the effect of the capacitance between the input and output terminals. The apparently increased input capacity due to the Miller effect results as follows:
C
M
=C(1+Av)
where −Av is the gain and C is the feedback capacitance.
Although the term Miller effect usually refers to capacitances, any impedance connected between the input and another node showing gain can modify the amplifier input impedance with this effect.
Since different applications require different upper corner frequencies fcu, a variable RC low-pass filter has been integrated.
In one reference, this variation was achieved by adjusting the LNA bias current Iss, creating a variation of the noise behavior. O. F. Cota, et al., “In-vivo characterization of a 0.8-3 \muV RMS input-noise versatile CMOS pre-amplifier,” Neural Engineering (NER), 2015 7th International IEEE/EMBS Conference on, 2015, S. 458-461. To avoid this unwanted coupling, a capacitance multiplier was proposed which uses the control current OTA from J. Ramirez-Angulo, et al., “Gain programmable current mirrors based on current steering,” Electronics Letters, vol. 42, no. 10, S. 559-560, 2006 and which is connected to the second stage as is described in J. A. Ruiz, et al., “Three novel improved CMOS capacitance scaling schemes,” in Circuits and Systems (ISCAS), Proceedings of 2010 IEEE International Symposium on, 2010, S. 1304-1307. The capacitance multiplication factor (from 50 pF to 5 nF) is set by the differential input VGC±, the bias current of 56 μA and an area of 0.013 mm2.
The chip uses the X-Fab 0.35 μm library 10-bit SAR-ADC and integrates a user-defined flip-flop-based parallel-serial converter. The 16-bit little-endian output is combined as in J. Ramirez-Angulo, S. R. Garimella, A. J. López-Martin, and R. G. Carvajal, “Gain programmable current mirrors based on current steering,” Electronics Letters, vol. 42, no. 10, S. 559-560, 2006, where S represents the start token bits (H L), bits C3-C0 represent the channel number and bits D9-D0 represent the ADC sample values.
The power consumption of the chip is summarized in Table 2:
The chip shown in
Although the chip is designed for digital output, it contains test pins to support its characterization, such as the analog outputs of the preamplifier and the low-pass filter of channels 1 and 5.
Table 3, below, shows I/O pins of the LNA8 chip. Underlined pins represent outputs.
DSOUT(½)
V
OUTN/P(1, 5)
V
OUT1/5
Q1
0-3
EOC1
The ADCs can be clocked with two serial digital outputs up to 1 MHz.
The LNA8 recording system has variable corner frequencies fcU, fcL in each case by varying the potentials VTUNE and VGC±.
The spectral noise density of the amplifier was measured for different bias currents and bandwidth setting voltages.
The graphical representation in
The acquisition system has been tested with bioelectric in-vivo signals as shown in
The foregoing description shows the implementation of a biopotential acquisition system with 8 channels.
Although the best noise efficiency factor is achieved by the design that uses BJT transistors, this has the disadvantage that a residual DC current of 20 nA remains, which can lead to electrode corrosion in the long run.
The capacitance multiplier fulfilled its function of providing a wide range for the upper cut-off frequency.
However, since it was dimensioned for minimum area and power consumption, the noise behavior could not be kept below 1 μVRMS without a capacitance multiplier; the noise behavior can be maintained by software filtering.
Table 4 shows a comparison of the shown low-noise amplifier (LNA) with other systems.
Compared to the previous work in O. F. Cota, et al., the present design integrated the other blocks of the desired system.
The amplifier area has been reduced by a factor of four and an analog output.
The invention shows the successful implementation and the testing of a versatile bioelectric signal acquisition chip with 8 channels. The amplified channels are selected from two analog multiplexers and are output by two SPI-compatible 16-bit data streams. The total integrated input noise can be reduced to *(sim. value) 0.6 μVRMS for bandwidths between 1 Hz and 10 kHz. The acquisition system has been tested for ECG and EMG applications.
Number | Date | Country | Kind |
---|---|---|---|
10 2016 103 073.2 | Feb 2016 | DE | national |
This application is the United States entry of International Application No. PCT/EP2017/054057, filed Feb. 22, 2017, which is related to and claims the benefit of priority of German Application No. 10 2016 103 073.2, filed Feb. 22, 2016. The contents of International Application No. PCT/EP2017/054057 and Gelman Application No. 10 2016 103 073.2 are incorporated by reference herein in their entireties.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2017/054057 | 2/22/2017 | WO | 00 |